<- Go home

Added to YB: 2015-12-10

Pitch date: 2015-12-10

ADPT:US [bullish]

Adaptive Biotechnologies Corporation

-34.66%

current return

Author Info

No bio for this author

Company Info

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases.

Market Cap

$4.0B

Pitch Price

$39.01

Price Target

N/A

Dividend

N/A

EV/EBITDA

-581.61

P/E

-60.22

EV/Sales

12.98

Sector

Life Sciences Tools and Services

Category

N/A

Show full summary:
ADEPTUS HEALTH INC ADPT:US

A summary for this pitch has not been created yet.

Read full article (0 min)